The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population

Date
2016
Author
Olgunturk, Rana
Gursel, Turkiz
ALTUN BİNGÖL, Demet
TUNAOĞLU, FATMA SEDEF
OĞUZ, AYŞE DENİZ
Taskin, Birce Dilge
KULA, SERDAR
ERGÜN, MEHMET ALİ
Metadata
Show full item record
Abstract
Objective: The aim was to investigate the frequency of genetic polymorphisms of cytochrome P4502C9 (CYP2C9) and vitamin K epoxide reductase complex subunit1 (VKORC1) and determine the effect of these polymorphisms on warfarin dose requirements in pediatric patients.
URI
http://hdl.handle.net/20.500.12627/176505
https://doi.org/10.14744/anatoljcardiol.2015.6150
Collections